2019

Duopharma Biotech Signs MOU with KPJ Healthcare Berhad to Collaborate in Development Initiatives of Halal Pharmaceuticals

Kuala Lumpur, December 18, 2019 – Duopharma Biotech Berhad (formerly known as CCM Duopharma Biotech Berhad) (“Duopharma Biotech”) today unveiled its new corporate logo and name at an external rebranding launch. The Company obtained shareholders’ approval for the new corporate identity earlier this year. Duopharma Biotech, which is majority owned by Permodalan Nasional Berhad (PNB), is the largest Malaysian pharmaceutical manufacturer and trading company.

Duopharma Biotech Records 14.52 per cent increase in revenue for nine months ended 30 September 2019

Kuala Lumpur, November 29, 2019 – Duopharma Biotech Berhad (formerly known as CCM Duopharma Biotech Berhad) (“Duopharma Biotech”) unaudited revenue grew 14.52 per cent to RM438.71 million for nine months ended 30 September 2019 (Q3 FY2019), from RM383.09 million in the corresponding period last year, mainly due to the higher demand from private and public health sector.

300 Kids Hone Their Tennis Skills at CHAMPS®-Sponsored ‘Tennis Malaysia First Serve Mini Tennis’

Kuala Lumpur, September 3, 2019– The ‘Tennis Malaysia First Serve Mini Tennis’ Carnival was in full swing at the Jalan Sultan Abdul Halim’s National Tennis Centre recently, with some 300 students, aged seven to nine, participating in the event organised by the Lawn Tennis Association of Malaysia (LTAM) and sponsored by CHAMPS®, Malaysia’s leading children health supplement brand manufactured and distributed by Duopharma Biotech Berhad, (formerly known as CCM Duopharma Biotech Berhad) (“Duopharma Biotech”).

Duopharma Biotech Declares 1.0 Sen Interim Dividend for H1 FY2019

Kuala Lumpur, August 30, 2019 – Duopharma Biotech Berhad’s (formerly known as CCM Duopharma Biotech Berhad) (“Duopharma Biotech”) Board of Directors has recommended a single tier interim dividend of 1.0 sen per share based on paid up capital of 680,106,506 shares amounting to approximately RM6.80 million for the current financial period ended 30 June 2019.

Negeri Sembilan Mufti gets First Hand Info on Manufacturing of Halal Pharmaceuticals

Bangi, Selangor, July 17, 2019 – Duopharma Biotech Berhad (formerly known as CCM Duopharma Biotech Berhad) (“Duopharma Biotech”)’s commitment in enhancing halal integrity for pharmaceutical products continues to attract the interest of various groups in Malaysia, with the latest being the visit by the Negeri Sembilan Mufti and Fatwa office led by the mufti himself, Datuk Hj Mohd Yusof Bin Hj. Ahmad.

Duopharma Biotech Achieves Key Milestones in First Year as Independent Entity

Shah Alam, May 31, 2019 – Duopharma Biotech Berhad’s (Duopharma Biotech) (formerly known as CCM Duopharma Biotech Berhad) has accomplished several key milestones in its first year as an independent entity, by continuing to pioneer many firsts in the local pharmaceutical landscape.

Duopharma Biotech Treated Underprivileged Kids to Buka Puasa

Bangi, May 28, 2019 – The holy month of Ramadan is more than abstaining ourselves from eating and drinking from dawn until dusk. It is a time for reflection and focus on religious obligations, which teaches us to be grateful for all the blessings and practice compassion towards the less fortunate.

Duopharma Biotech Berkerjasama dengan PDRM untuk Mengurangkan Kadar Kemalangan Menerusi Kempen Keselamatan Jalan Raya

KUALA LUMPUR, 28 Mei 2019 – Syarikat farmaseutikal terkemuka Duopharma Biotech Berhad (dahulunya di kenali sebagai CCM Duopharma Biotech Berhad) (“Duopharma Biotech”) telah berkerjasama dengan Jabatan Siasatan dan Penguatkuasaan Trafik Polis Diraja Malaysia (PDRM) bagi melancarkan Kempen Op Selamat 15/2019 bersama Proviton sempena musim perayaan ini dengan slogan “Rumah Selamat Sampai ke Destinasi”.

Duopharma Biotech (Formerly Known as CCM Duopharma) 1Q Profit Up 41.73% on Higher Demand from Private and Public Health Sector

Kuala Lumpur, May 20, 2019 – Duopharma Biotech Berhad’s (Duopharma Biotech) (formerly known as CCM Duopharma Biotech Berhad) first quarter Profit before tax (PBT) rose 41.73 per cent to RM18.79 million for the period ending March 31, 2019 from RM13.26 million in the corresponding period ended March 31, 2018 on the back of higher demand from the private and public health sector.

CHAMPS® Contributes RM50,000 to ‘First Serve’ National Tennis Development Programme

Kuala Lumpur, April 29, 2019- Efforts to encourage and unearth more budding talents to take up tennis with the hope of representing the nation in the future, were given a shot in the arm recently when CHAMPS®, Malaysia’s leading children health supplement brand, pledged RM50,000 for the organising of the First Serve Tennis Malaysia Kid’s Grand Prix 2019.